tiprankstipranks
Monopar Therapeutics Inc (MNPR)
NASDAQ:MNPR
Want to see MNPR full AI Analyst Report?

Compare Monopar Therapeutics Inc (MNPR) vs. Competitors

574 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Monopar Therapeutics Inc
$56.22
$422.84M
-30.03
78.10%
8 Buy
0 Hold
0 Sell
Strong Buy
Cardiff Oncology
$1.80
$121.70M
-2.24
-38.19%
6 Buy
0 Hold
0 Sell
Strong Buy
Vanda
$7.27
$372.24M
-2.11
45.99%
4 Buy
0 Hold
0 Sell
Strong Buy
Verastem
$6.58
$372.58M
-3.56
-43.32%
8 Buy
0 Hold
0 Sell
Strong Buy
Mereo Biopharma Group Plc
$0.34
$44.42M
-1.97
-87.81%
3 Buy
2 Hold
0 Sell
Moderate Buy
Silence Therapeutics
$7.53
$292.85M
-4.17
28.10%
4 Buy
0 Hold
1 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
MNPR
Monopar Therapeutics Inc
63.12
27.67
78.05%
CRDF
Cardiff Oncology
1.78
-1.25
-41.25%
VNDA
Vanda
6.19
1.86
42.96%
VSTM
Verastem
4.24
-4.07
-48.98%
MREO
Mereo Biopharma Group Plc
0.28
-1.96
-87.59%
SLN
Silence Therapeutics
6.20
1.14
22.53%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts